Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
about
Relation between viral fitness and immune escape within the hepatitis C virus proteaseHierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.Identification of an HLA-A*0201-restricted T-cell epitope on the MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis, by MPT51 overlapping peptide screening.Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopesDifferences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathiesDifferent in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.An assay for peptide binding to HLA-Cw*0102.Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hostsLow dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopes.Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancerThe potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
P2860
Q27478333-CB948087-C027-461A-B3F1-2CC36ACE0DE6Q30452613-9CB40727-6046-49A1-8EDA-8EA414660CB4Q30452642-8D0E4FA5-6728-4B66-B9DF-D5D57FBE182EQ33315752-81649B69-A83A-4319-A918-5B48005E3EA7Q33390630-35D2649D-58A0-432A-8538-796C856A40B3Q33517118-AB04EBAC-3674-402E-83D1-11BBAC7F413BQ37362148-35E13DD8-155A-410E-9CCF-8252D1AC9366Q40756949-B796947A-3089-4179-AE86-35FDC43112A7Q40928687-C761EC52-CD4F-4E09-BD26-F192E450A717Q41913763-2E7E14A0-5C43-461A-80D1-DF1DD2BE566FQ43048872-444936B5-5B37-45B3-88C5-8E72028CC0E3Q45739675-CA15159C-FB26-490E-AC98-E0851A5A947DQ57209274-4165588B-3852-4943-994B-26A14BA32197Q58705894-3E1C2AC1-A646-4036-94D4-EA969B5F7BCA
P2860
Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Assessment of major histocompa ...... ptide loading-deficient cells.
@en
Assessment of major histocompa ...... ptide loading-deficient cells.
@nl
type
label
Assessment of major histocompa ...... ptide loading-deficient cells.
@en
Assessment of major histocompa ...... ptide loading-deficient cells.
@nl
prefLabel
Assessment of major histocompa ...... ptide loading-deficient cells.
@en
Assessment of major histocompa ...... ptide loading-deficient cells.
@nl
P2093
P356
P1476
Assessment of major histocompa ...... ptide loading-deficient cells.
@en
P2093
Franksson L
P304
P356
10.1002/EJI.1830221033
P407
P577
1992-10-01T00:00:00Z